SCHEMBL7899607

SCHEMBL7899607

CC1CN(c2ccc(OCc3ccccc3)cc2)CCC1N

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.49
DPP4 P27487 4/20 0.49
HRH3 Q9Y5N1 3/20 0.49
KDM4E B2RXH2 2/20 0.47
MCHR1 Q99705 1/20 0.47
LTA4H P09960 1/20 0.45
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 2/20 0.43
FDFT1 P37268 1/20 0.43
S1PR5 Q9H228 1/20 0.43
GAA P10253 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7891590 0.81 PRMT5 (0.55) ACACBHRH3KDM4EMCHR1LTA4H
SCHEMBL7891504 0.80 HRH3 (0.47) ACACBHRH3KDM4EMCHR1LTA4H
SCHEMBL20875967 0.80 MAOB (0.54) HRH3MCHR1LTA4HRAB9ANPC1
SCHEMBL7899149 0.78 EPHX2 (0.54) ACACBKDM4ELTA4HRAB9AALDH1A1
SCHEMBL7891567 0.77 NPC1 (0.46) ACACBHRH3KDM4EMCHR1LTA4H
SCHEMBL7891575 0.77 NPC1 (0.46) ACACBHRH3KDM4EMCHR1LTA4H
SCHEMBL738630 0.76 PRMT5 (0.56) ACACBHRH3KDM4EMCHR1LTA4H
SCHEMBL17888549 0.76 RAB9A (0.68) ACACBHRH3KDM4ELTA4HRAB9A
SCHEMBL7898013 0.75 GRM2 (0.48) ACACBHRH3KDM4EMCHR1RAB9A
SCHEMBL7898016 0.75 GRM2 (0.48) ACACBHRH3KDM4EMCHR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed